Sequenom's Q3 Revenues Decline 21 Percent | GenomeWeb

This article has been modified to add information from Sequenom's conference call.

NEW YORK (GenomeWEb) – Sequenom reported after the close of the market today that its third quarter 2015 revenues were down 21 percent compared to the third quarter of 2014.

The San Diego, California-based molecular diagnostics company had third quarter revenues totaling $29.9 million compared to $37.9 million in the third quarter 2014. It missed the Wall Street estimate of $31.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.